Ruben Mesa, MD, Hematology, San Antonio, TX, University Health System

RubenAMesaMD

Hematology San Antonio, TX

Hematologic Oncology, Myeloproliferative Disorder Hematology-Oncology

Director, Mays Cancer Center at UT Health San Antonio MD Anderson

Dr. Mesa is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Mesa's full profile

Already have an account?

Summary

  • Dr. Ruben Mesa is a hematologist in San Antonio, TX and is affiliated with multiple hospitals in the area, including University Health System and UT Health San Antonio MD Anderson Cancer Center. He received his medical degree from Mayo Clinic School of Medicine and has been in practice 22 years. He also speaks multiple languages, including Spanish. He specializes in hematologic oncology and myeloproliferative disorder hematology-oncology and is experienced in eosinophilia, hematologic oncology, polycythemia vera, primary myelofibrosis, and essential thrombocytosis.

Education & Training

  • Mayo School of Graduate Medical Education
    Mayo School of Graduate Medical EducationFellowship, Hematology/Oncology, 1998 - 2002
  • Mayo School of Graduate Medical Education
    Mayo School of Graduate Medical EducationResidency, Internal Medicine, 1995 - 1998
  • Mayo Clinic School of Medicine
    Mayo Clinic School of MedicineClass of 1995

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 2017 - 2022
  • AZ State Medical License
    AZ State Medical License 2009 - 2021
  • MN State Medical License
    MN State Medical License 1996 - 2013
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2013-2014
  • Top Doctors:Arizona State Castle Connolly, 2013
  • America's Top Doctors for Cancer Castle Connolly, 2012-2013
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Phase 2 Study of Luspatercept in Patients with Myelofibrosis-Associated Anemia
    Ruben A Mesa, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Persistent Leukocytosis in Polycythemia Vera Is Associated with Disease Evolution but Not Thrombosis: An Analysis from a 520-Patient Retrospective Multi-Center Database
    Ruben A. Mesa, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Patient-Reported Outcomes (PRO) Data from Patients (Pts) with Essential Thrombocythemia (ET) Enrolled in the MOST Study
    Ruben A. Mesa, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Join now to see all

Lectures

  • SOHO 2020: Bringing 'MPN Awareness' to Hematology Community 
    Mayo School of Continuous Professional Development, Phoenix, Arizona - 9/14/2013
  • Pacritinib Demonstrates Efficacy Versus Best Available Therapy in Myelofibrosis Patients with Severe Thrombocytopenia in Two Phase 3 Studies 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Dynamic and Time-to-Event Analyses Demonstrate Marked Reduction in Transfusion Requirements for Janus Kinase Inhibitor_Na¥ve Myelofibrosis Patients Treated with Momelo... 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Join now to see all

Press Mentions

  • What Makes a Good Leader?
    What Makes a Good Leader?November 26, 2020 12:12
  • Expert Highlights RESPONSE Results with Ruxolitinib in Polycythemia Vera
    Expert Highlights RESPONSE Results with Ruxolitinib in Polycythemia VeraOctober 24, 2020 18:54
  • Expert Perspectives: Management of Acute Myeloid Leukemia
    Expert Perspectives: Management of Acute Myeloid LeukemiaOctober 24, 2020 18:53
  • Join now to see all

Grant Support

  • Apoptosis In Myelofibrosis With Myeloid MetaplasiaNational Cancer Institute2004–2006
  • Apoptosis In Myelofibrosis With Myeloid MetaplasiaNational Cancer Institute2002–2003
  • Truncated C-Erbb Receptors In Ovarian CarcinomasNational Cancer Institute1992

Professional Memberships

Other Languages

  • Spanish

Hospital Affiliations